Activist investor’s intervention adds to buzz surrounding BMS.
Company reports better than expected full year figures.
Speculation mounting that Pfizer and others could try for $90 bn plus merger
PRAC to review Uptravi after five deaths in France.
Company needs to make acquisition to grow, admits CEO.
Japanese firm has set money aside for emerging markets M&A.
Cello Health acquires NJ based Defined Health